Catégorie : publi-coronavirus
Rapport Covid-19 de la DREES au 30 janvier 2022
Rapport Covid-19 de la DREES Le nombre d’hospitalisations liées à la vague Omicron est en baisse, pour les patients admis…
Nos publications en Sciences Humaines et Sociales
Ward JK, Alleaume C, Peretti-Watel P; COCONEL Group. The French public’s attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Social Science and Medicine, 265:113414. doi:10.1016/j.socscimed.2020.113414….
Meta-analysis on chloroquine derivatives and COVID-19 mortality – October, 20, 2020 Update
Suppl data METACOVID 19 oct 2020
Rapport du Pr Didier Raoult remis aux Sénateurs membres de la commission d’enquête
Rapport du Professeur Didier Raoult remis aux Sénateurs de la Commission d’enquête pour l’évaluation des politiques publiques face aux grandes pandémies à la lumière de la crise sanitaire de la Covid-19 et de sa gestion, à l’…
HYDROXYCHLOROQUINE AND THE BURDEN OF PROOF
HYDROXYCHLOROQUINE AND THE BURDEN OF PROOF
An Urgent Call to Depoliticize Medicine in the COVID-19 Pandemic
Kass HCQ White Paper 2020
Meta-analysis on chloroquine derivatives and COVID-19 mortality – September, 16, 2020 Update
Relais de brève ☛ Lire la suite sur le site relayé…
Natural history and therapeutic options for COVID-19
Abstract
Introduction
COVID-19 presents benign forms in young patients who frequently present with anosmia. Infants are rarely infected, while severe forms occur in patients over 65 years of age with comorbidities, including hypertensi…
Conférence de presse à l’IHU le 27/08/2020, Présentation de Didier Raoult
Relais de brève ☛ Lire la suite sur le site relayé…
Méta-analyse en temps réel pour HCQ / mortalité / COVID
Relais de brève ☛ Lire la suite sur le site relayé…
Nombre de décès liés au COVID-19 en France, par semaine
Relais de brève ☛ Lire la suite sur le site relayé…
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
Abstract
Background
In our institute in Marseille, France, we initiated early and massive screening for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment with hydroxychloroquine and azithromycin (HCQ-AZ) was proposed…
Remdesivir investigational trials in COVID-19: a critical reappraisal
Abstract
During outbreak of emerging disease, the most important aim is to discover an effective drug to save life. Consequently, a lot of effort are generally made by the industry to promote clinical trials with new drugs. Here we review evi…
Clinical Efficacy of Chloroquine derivatives in COVID-19 Infection: Comparative meta-analysis between the Big data and the real world
Abstract
In the context of the current COVID-19 pandemic, we conducted a meta-analysis on the effects of chloroquine derivatives in patients, based on unpublished and published reports available publicly on the internet as of May, 27, 2020. T…
Influence of conflicts of interest on public positions in the COVID-19 era, the case of Gilead Sciences
Abstract
Fundings and gifts from the pharmaceutical industry have an influence on the decisions made by physicians and medical experts. In the context of the COVID-19 epidemic, several treatments are available to treat patients infected with …
Bibliographie
Vojo Deretic, Graham S Timmins. Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells. bioRxiv 2020.03.29.008631; […]
Pré-Prints IHU
Le site des prépublications de l’IHU sur le COVID-19
Compte-tenu de la vitesse d’évolution de l’épidémie et des besoins de renseignements permanents pour la communauté scientifique, associé à la difficulté des déplacements, la fondation a déci…
